Colorectal cancer risk after colonoscopy in elderly diabetes patient and men
老年糖尿病患者和男性结肠镜检查后结直肠癌的风险
基本信息
- 批准号:8118428
- 负责人:
- 金额:$ 43.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Provided by Applicant): Colorectal cancer (CRC) is the second leading cause of cancer death in the U.S. Colonoscopy is widely used to screen for CRC. Current guidelines recommend screening colonoscopy once every 10 years in average risk patients over >50 year who have no polyps identified at colonoscopy (i.e., negative colonoscopy). However, the prevalence of CRC and polyps increase with age. In addition, nearly 1/4 of the U.S. population over 60 years of age have diabetes mellitus (DM). Recent data suggest patients with diabetes mellitus (DM) have an increased risk of CRC. Furthermore, population-based cancer incidence data have consistently suggested a higher incidence of CRC among men vs. women, and the disparity is most striking among those >65 years. Hence, the negative predictive value of a negative colonoscopy may be lower in patients >65 years who are male or have DM. As a result, there is uncertainty whether the recommended 10-year interval between screening colonoscopies in whom no polyps were identified should apply to elderly men or elderly DM patients. We hypothesize that among patients over the age of 65, the risk of CRC following a negative colonoscopy is higher in men vs. women, and in DM patients vs. non-DM patients. To test this hypothesis, we have designed a population-based cohort study using the linked SEERMedicare
data. The study will determine among the SEER-Medicare population, 1) whether men who have
undergone a negative colonoscopy have a higher subsequent incidence of CRC than women with a
negative colonoscopy; 2) whether DM patients who have undergone a negative colonoscopy have a higher subsequent incidence of CRC than non-DM patients with a negative colonoscopy; 3) whether men or DM patients who have undergone a negative colonoscopy have a lower incidence of CRC than the general SEER-Medicare population who have not undergone colonoscopy and whether the lower incidence persists for up to 10 years; 4) determine the absolute incidence by time of CRC following a colonoscopy without polyps for men, women, all patients with diabetes, men with diabetes, and women with diabetes. Both relative and absolute risks will be examined during the follow-up period. Subgroup analysis will examine the risk for proximal colon cancer and the combined effect of male sex and DM.
Relevance to Public Health: CRC is a common cause of death among the elderly population. Screening for colorectal cancer can reduce the risk of cancer and cancer-related mortality. Given the increased incidence of CRC in elderly male patients or elderly DM patients, it is important to determine whether the recommended 10-year interval between colonoscopies without polyps offers adequate protection to these high risk groups. Our study will help establish the appropriate time interval for elderly men and elderly DM patients to undergo a second colonoscopy following a negative colonoscopy so that they will not be facing an unacceptably high rate of preventable CRC morbidity and mortality.
描述(由申请人提供):结直肠癌(CRC)是美国癌症死亡的第二大原因,结肠镜检查被广泛用于筛查结直肠癌。目前的指南建议,在50岁以上的平均风险患者中,结肠镜检查未发现息肉(即结肠镜检查阴性),每10年进行一次结肠镜检查。然而,结直肠癌和息肉的患病率随着年龄的增长而增加。此外,近1/4的美国60岁以上人口患有糖尿病(DM)。最近的数据显示,糖尿病(DM)患者发生结直肠癌的风险增加。此外,基于人群的癌症发病率数据一致表明,男性CRC的发病率高于女性,这种差异在65岁以上的人群中最为显著。因此,65岁以下男性或糖尿病患者结肠镜检查阴性的预测价值可能较低。因此,推荐的未发现息肉的结肠镜检查间隔10年是否适用于老年男性或老年糖尿病患者尚不确定。我们假设在65岁以上的患者中,结肠镜检查阴性后结直肠癌的风险男性高于女性,糖尿病患者高于非糖尿病患者。为了验证这一假设,我们设计了一项基于人群的队列研究,使用相关的SEERMedicare
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Minimal benefit of earlier-than-recommended repeat colonoscopy among US Medicare enrollees following a negative colonoscopy.
对于结肠镜检查阴性后的美国医疗保险参保者来说,早于建议的重复结肠镜检查的好处微乎其微。
- DOI:10.1111/apt.12902
- 发表时间:2014
- 期刊:
- 影响因子:7.6
- 作者:Yang,Y-X;French,B;Localio,AR;Brensinger,CM;Lewis,JD
- 通讯作者:Lewis,JD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YU-XIAO YANG其他文献
YU-XIAO YANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YU-XIAO YANG', 18)}}的其他基金
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
分剂量结肠镜检查肠道准备方案的比较效果
- 批准号:
10216343 - 财政年份:2017
- 资助金额:
$ 43.84万 - 项目类别:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
分剂量结肠镜检查肠道准备方案的比较效果
- 批准号:
9293611 - 财政年份:2017
- 资助金额:
$ 43.84万 - 项目类别:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
分剂量结肠镜检查肠道准备方案的比较效果
- 批准号:
9600613 - 财政年份:2017
- 资助金额:
$ 43.84万 - 项目类别:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
分剂量结肠镜检查肠道准备方案的比较效果
- 批准号:
10201717 - 财政年份:2017
- 资助金额:
$ 43.84万 - 项目类别:
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS
外源性胰岛素治疗对 PTS 结直肠腺瘤风险的影响
- 批准号:
8046051 - 财政年份:2011
- 资助金额:
$ 43.84万 - 项目类别:
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS
外源性胰岛素治疗对 PTS 结直肠腺瘤风险的影响
- 批准号:
8586854 - 财政年份:2011
- 资助金额:
$ 43.84万 - 项目类别:
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS
外源性胰岛素治疗对 PTS 结直肠腺瘤风险的影响
- 批准号:
8390430 - 财政年份:2011
- 资助金额:
$ 43.84万 - 项目类别:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
慢性质子泵抑制剂治疗对骨矿物质密度和骨的影响
- 批准号:
8527717 - 财政年份:2009
- 资助金额:
$ 43.84万 - 项目类别:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
慢性质子泵抑制剂治疗对骨矿物质密度和骨的影响
- 批准号:
7784005 - 财政年份:2009
- 资助金额:
$ 43.84万 - 项目类别:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
慢性质子泵抑制剂治疗对骨矿物质密度和骨的影响
- 批准号:
8123411 - 财政年份:2009
- 资助金额:
$ 43.84万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
- 批准号:82371223
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
- 批准号:82373139
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
- 批准号:82372089
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
- 批准号:82371997
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
- 批准号:82372724
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
- 批准号:82371912
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
DRAM1与VAMP8相互作用调控自噬融合以促进肺癌细胞血管外渗的分子机制研究
- 批准号:32000523
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
SAMMSON-CARF-p53信号轴调控黑色素瘤适应性耐药的机制研究
- 批准号:32000541
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
- 批准号:
10820067 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis
结直肠癌的饮食预防:针对胆汁酸/肠道微生物组轴
- 批准号:
10723195 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Monitoring Community Efforts to Increase Colorectal Cancer Screening in African Americans
监测社区为增加非裔美国人结直肠癌筛查所做的努力
- 批准号:
10627341 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Defining the changing microbiome composition and host-microbe mechanistic effects following Apc inactivation during colorectal cancer pathogenesis
定义结直肠癌发病过程中 Apc 失活后微生物组组成的变化和宿主微生物机制效应
- 批准号:
10750676 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Illuminating the evolutionary history of colorectal cancer metastasis: basic principles and clinical applications
阐明结直肠癌转移的进化史:基本原理和临床应用
- 批准号:
10906574 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Implementing evidence based colorectal cancer screening in rural clinics
在农村诊所实施循证结直肠癌筛查
- 批准号:
10567653 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
- 批准号:
10697474 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people
阿拉斯加原住民结直肠癌肿瘤和免疫微环境的深入分子和细胞分析
- 批准号:
10651205 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Elucidating the role of gut microbiota in colitis-associated colorectal cancer
阐明肠道微生物群在结肠炎相关结直肠癌中的作用
- 批准号:
10564074 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:
Transcriptome and spatial analyses of tumor environment in addressing colorectal cancer racial and ethnical disparities
肿瘤环境的转录组和空间分析在解决结直肠癌种族和民族差异方面的作用
- 批准号:
10743201 - 财政年份:2023
- 资助金额:
$ 43.84万 - 项目类别:














{{item.name}}会员




